812 related articles for article (PubMed ID: 8971089)
1. Interactions of the kallikrein-kinin and renin-angiotensin systems in experimental diabetes.
Vora JP; Oyama TT; Thompson MM; Anderson S
Diabetes; 1997 Jan; 46(1):107-12. PubMed ID: 8971089
[TBL] [Abstract][Full Text] [Related]
2. Activity and functional significance of the renal kallikrein-kinin-system in polycystic kidney disease of the rat.
Braun C; Kleemann T; Hilgenfeldt U; Riester U; Rohmeiss P; van der Woude FJ
Kidney Int; 2002 Jun; 61(6):2149-56. PubMed ID: 12028455
[TBL] [Abstract][Full Text] [Related]
3. Acute renal hemodynamic effects of ACE inhibition in diabetic hyperfiltration: role of kinins.
Komers R; Cooper ME
Am J Physiol; 1995 Apr; 268(4 Pt 2):F588-94. PubMed ID: 7733315
[TBL] [Abstract][Full Text] [Related]
4. Kinins are involved in the antiproteinuric effect of angiotensin-converting enzyme inhibition in experimental diabetic nephropathy.
Tschöpe C; Seidl U; Reinecke A; Riester U; Graf K; Schultheiss HP; Hilgenfeldt U; Unger T
Int Immunopharmacol; 2003 Mar; 3(3):335-44. PubMed ID: 12639811
[TBL] [Abstract][Full Text] [Related]
5. Role of kinins in the renal response to enalaprilat in normotensive and hypertensive rats.
Fitzgibbon WR; Jaffa AA; Mayfield RK; Ploth DW
Hypertension; 1996 Feb; 27(2):235-44. PubMed ID: 8567046
[TBL] [Abstract][Full Text] [Related]
6. Chronic kinin blockade and effect of ramipril in renal adaptation to sodium restriction.
Jover B; Hérizi A; Mimran A
Hypertension; 1996 Jan; 27(1):79-84. PubMed ID: 8591893
[TBL] [Abstract][Full Text] [Related]
7. Effect of angiotensin-converting enzyme inhibition on circulating and local kinin levels.
Johnston CI; Clappison BH; Anderson WP; Yasujima M
Am J Cardiol; 1982 Apr; 49(6):1401-4. PubMed ID: 6122371
[TBL] [Abstract][Full Text] [Related]
8. Functional, biochemical, and molecular investigations of renal kallikrein-kinin system in diabetic rats.
Tschöpe C; Reinecke A; Seidl U; Yu M; Gavriluk V; Riester U; Gohlke P; Graf K; Bader M; Hilgenfeldt U; Pesquero JB; Ritz E; Unger T
Am J Physiol; 1999 Dec; 277(6):H2333-40. PubMed ID: 10600853
[TBL] [Abstract][Full Text] [Related]
9. Contribution of the renin-angiotensin and kallikrein-kinin systems to short-term variability of blood pressure in two-kidney, one-clip hypertensive rats.
Ponchon P; Elghozi JL
Eur J Pharmacol; 1996 Feb; 297(1-2):61-70. PubMed ID: 8851167
[TBL] [Abstract][Full Text] [Related]
10. The role of nitric oxide, adrenergic activation and kinin-degradation in blood pressure homeostasis following an acute kinin-induced hypotension.
Bjørnstad-Ostensen A; Berg T
Br J Pharmacol; 1994 Dec; 113(4):1567-73. PubMed ID: 7889314
[TBL] [Abstract][Full Text] [Related]
11. Effect of an angiotensin II and a kinin receptor antagonist on the renal hemodynamic response to captopril.
Fenoy FJ; Scicli G; Carretero O; Roman RJ
Hypertension; 1991 Jun; 17(6 Pt 2):1038-44. PubMed ID: 1646165
[TBL] [Abstract][Full Text] [Related]
12. The renoprotective effect of angiotensin-converting enzyme inhibitors in experimental chronic renal failure is not dependent on enhanced kinin activity.
Nabokov A; Amann K; Gassmann P; Schwarz U; Orth SR; Ritz E
Nephrol Dial Transplant; 1998 Jan; 13(1):173-6. PubMed ID: 9481735
[TBL] [Abstract][Full Text] [Related]
13. Contribution by bradykinin to the natriuretic response to the angiotensin converting enzyme inhibitor ramiprilat in spontaneously hypertensive rats.
Sakamoto T; Chen C; Lokhandwala MF
Naunyn Schmiedebergs Arch Pharmacol; 1994 Jul; 350(1):84-9. PubMed ID: 7935859
[TBL] [Abstract][Full Text] [Related]
14. Kinin, a mediator of diabetes-induced glomerular hyperfiltration.
Jaffa AA; Rust PF; Mayfield RK
Diabetes; 1995 Feb; 44(2):156-60. PubMed ID: 7859934
[TBL] [Abstract][Full Text] [Related]
15. Role of angiotensin II and bradykinin in experimental diabetic nephropathy. Functional and structural studies.
Allen TJ; Cao Z; Youssef S; Hulthen UL; Cooper ME
Diabetes; 1997 Oct; 46(10):1612-8. PubMed ID: 9313758
[TBL] [Abstract][Full Text] [Related]
16. Effect of chronic bradykinin B2 receptor blockade on blood pressure of conscious Dahl salt-resistant rats.
Mukai H; Fitzgibbon WR; Ploth DW; Margolius HS
Br J Pharmacol; 1998 May; 124(1):197-205. PubMed ID: 9630360
[TBL] [Abstract][Full Text] [Related]
17. Chronic kinin receptor blockade attenuates the antihypertensive effect of ramipril.
Bao G; Gohlke P; Qadri F; Unger T
Hypertension; 1992 Jul; 20(1):74-9. PubMed ID: 1319960
[TBL] [Abstract][Full Text] [Related]
18. Role of bradykinin B2 receptors in the developmental changes of renal hemodynamics in the neonatal rat.
el-Dahr SS; Yosipiv IV; Lewis L; Mitchell KD
Am J Physiol; 1995 Dec; 269(6 Pt 2):F786-92. PubMed ID: 8594872
[TBL] [Abstract][Full Text] [Related]
19. Effects of angiotensin-converting enzyme inhibitors and angiotensin II type 1 receptor antagonists in rats with heart failure. Role of kinins and angiotensin II type 2 receptors.
Liu YH; Yang XP; Sharov VG; Nass O; Sabbah HN; Peterson E; Carretero OA
J Clin Invest; 1997 Apr; 99(8):1926-35. PubMed ID: 9109437
[TBL] [Abstract][Full Text] [Related]
20. Role of bradykinin in the neonatal renal effects of angiotensin converting enzyme inhibition.
Tóth-Heyn P; Mosig D; Guignard JP
Life Sci; 1998; 62(4):309-18. PubMed ID: 9450502
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
